Merck Vitiligo
Participation Information
This study is a 58 week long clinical trial to test a new potential product / medication for people with VITILIGO. There are 16 office visits and 4 telephone call visits over the 58 week duration. There is compensation for your participation if you qualify and take part in this trial. $1,700.00 in stipend provided if all study visits are attended and completed . Travel arrangements may be available for qualifying subjects based on location and sponsor approval.
To Qualify, you must meet the following INCLUSION CRITERIA:
1.) Clinical diagnosis / history of VITILIGO.
2.) Ages 18 thru 75
3.) Must have 4% or more Body Surface Area with VITILIGO
To Qualify, you must NOT meet the following EXCLUSION CRITERIA:
1.) MUST NOT be Pregnant or Breastfeeding
2.) MUST NOT have Segmental VITILIGO (if you are unsure, please contact Research Staff).
3.) MUST NOT have a current COVID-19 Infection at screening.
ClinicalTrials.gov Identifier: NCT06113328
https://clinicaltrials.gov/study/NCT06113328?cond=vitiligo&term=merck&rank=1
